CPIX - Cumberland Corp Total Debt to Capital

Cumberland Pharmaceuticals (CPIX) generates revenue by supplying specialized medications to US pharmacies and medical centers. This price action chart on the GURU.Markets platform shows a debt-to-equity ratio of 0.28. Stable income is driven by the inclusion of legacy brands in government procurement, while business resilience is bolstered by the diversification of niche products, although the lack of breakthrough innovations limits large-scale growth.

This indicator measures the degree of financial leverage by comparing total borrowed funds to equity to assess the business's dependence on external financing and default risks. By analyzing the ratio of total liabilities to shareholders' equity, an investor can see how the strong reputation of Cumberland Pharmaceuticals (CPIX) in the critical drug segment ensures balance sheet stability and protects the company from debt burdens.